Feature Channels: Drugs and Drug Abuse

Filters close
Released: 11-Jul-2024 9:05 AM EDT
Many Youths Continue to Take Opioids Months After Surgical Procedures
Children's Hospital of Philadelphia

A multi-institutional study found that 1 in 6 youths fill an opioid prescription prior to surgery, and 3% of patients were still filling opioid prescriptions three to six months after surgery, indicating persistent opioid use and possible opioid dependence.

Newswise: PSNaloxone%20tiktok%20graphic_0.jpg?itok=RC-AKWbB
Released: 10-Jul-2024 1:05 PM EDT
Research Highlights Tiktok as Tool in Opioid Harm Reduction
University of Nebraska-Lincoln

Welcome to Pocket Science: a glimpse at recent research from Husker scientists and engineers. For those who want to quickly learn the “What,” “So what” and “Now what” of Husker research.

   
Newswise:  Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice
8-Jul-2024 6:15 PM EDT
Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice
University of California, Los Angeles (UCLA), Health Sciences

New research led by UCLA Health has found a drug that treats insomnia works to prevent the addictive effects of the morphine opioids in mice while still providing effective pain relief.

Not for public release

This news release is embargoed until 8-Jul-2024 5:00 PM EDT Released to reporters: 2-Jul-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 8-Jul-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 8-Jul-2024 10:05 AM EDT
Pennsylvania's Opioid Prescriptions Plunge 38% After State Monitoring Program Implementation
The Rothman Orthopaedic Institute Foundation for Opioid Research and Education

In 2016, nearly 2 million opioid prescriptions were given to patients across the state. However, by the end of the study period in 2020, there was a 38 percent decrease in opioid prescriptions written, according to this study by Dr. Asif Ilyas.

1-Jul-2024 12:05 PM EDT
Experimental drug supercharges medicine that reverses opioid overdose
Washington University in St. Louis

Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.

Released: 2-Jul-2024 8:05 AM EDT
A new target for treatment of one type of macular degeneration
Ohio State University

A new study in mice hints at the promise of an eventual alternative treatment option for the “wet” version of age-related macular degeneration (AMD).

Not for public release

This news release is embargoed until 1-Jul-2024 5:00 PM EDT Released to reporters: 25-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jul-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 1-Jul-2024 5:05 AM EDT
The Supreme Court blocks Sackler Family Immunity
Newswise

The U.S. Supreme Court has blocked the Sackler family's bid for immunity from opioid-related lawsuits in a landmark decision. This ruling marks a pivotal moment in the ongoing opioid crisis, potentially reshaping how litigation against pharmaceutical companies is handled nationwide.

   
Newswise: As Restrictions on Cannabis and Psychedelics Ease, Americans Dabble with ‘Microdosing’
26-Jun-2024 8:05 PM EDT
As Restrictions on Cannabis and Psychedelics Ease, Americans Dabble with ‘Microdosing’
University of California San Diego

Loosening local, state and federal regulations on cannabis and psychedelics has increased Americans' interest in microdosing, according to a study from researchers at the University of California San Diego.

Released: 25-Jun-2024 2:55 PM EDT
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.’s drug epidemic
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s (FDA’s) final laboratory developed tests rule will impact patient access to essential tests. The survey found that, in spite of certain tests being exempt from the rule, it will still force many laboratories, particularly those in hospitals, to discontinue critical tests, including those needed to identify prescription and illegal drug use.

Not for public release

This news release is embargoed until 24-Jun-2024 5:00 PM EDT Released to reporters: 20-Jun-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Jun-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Jun-2024 9:05 AM EDT
Exploitation of supply chain monitoring loopholes fueled US opioid epidemic, study finds
Indiana University

New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration to regulate their supply.

9-Jun-2024 8:05 PM EDT
Multiracial individuals face unique challenges that may lead to high rates of alcohol and other drug use
Research Society on Alcoholism

Multiracial or mixed-race individuals – having parents or ancestors of different races – currently comprise more than 10 percent of the U.S. population. There is very little research on Multiracial individuals even though young adults in this group report high rates of alcohol and other drug (AOD) use: binge drinking, illicit drug use other than cannabis, and drug use disorders. New research explores what factors may contribute to high rates of substance use among this population. Results will be shared at the 47th annual scientific meeting of the Research Society on Alcohol (RSA) in Minneapolis, Minnesota.

     
9-Jun-2024 7:05 PM EDT
LGBTQ+ students in collegiate recovery programs are doing very well but have unique needs
Research Society on Alcoholism

Compared to their cisgender/heterosexual peers, LGBTQ+ college students are at an elevated risk of substance use and mental health challenges. While collegiate recovery programs provide an array of support to students in recovery from substance use disorders, scarce research has examined the unique needs of LGBTQ+ students within this population.

     
Newswise: Chilling discovery: Cold-sensing protein may pave the way for safer pain relief
18-Jun-2024 2:30 PM EDT
Chilling discovery: Cold-sensing protein may pave the way for safer pain relief
Arizona State University (ASU)

Research published in Science Advances traced the history of human’s ability to feel cold back to the molecular underpinnings of the cold and menthol sensor TRPM8 over hundreds of millions of years. The findings could lead to non-addictive pain medications, a crucial development given the opioid crisis.

Released: 14-Jun-2024 8:05 AM EDT
High out-of-pocket costs may be barrier to filling naloxone prescriptions, study shows
Michigan Medicine - University of Michigan

A study finds naloxone prescriptions, given to prevent opioid overdoses, are less likely to be filled when cost-sharing is higher, including at the start of a new health insurance year.



close
2.19927